» Articles » PMID: 3946744

Reversal of Abnormal Glucose Metabolism in Chronic Pancreatitis by Administration of Pancreatic Polypeptide

Overview
Journal Am J Surg
Specialty General Surgery
Date 1986 Jan 1
PMID 3946744
Citations 19
Authors
Affiliations
Soon will be listed here.
Abstract

Chronic pancreatitis, induced in dogs by pancreatic duct ligation, is associated with glucose intolerance due to insulin deficiency, reduced hepatic sensitivity to insulin, and a marked deficiency of pancreatic polypeptide. Treatment with a 14 day continuous subcutaneous infusion of pancreatic polypeptide resulted in improved oral glucose tolerance and improved hepatic glucose responses to insulin in dogs with chronic pancreatitis. No effect of continuous subcutaneous infusion of pancreatic polypeptide was seen in the control dogs. The time course of the effect of continuous subcutaneous infusion on the hepatic response to insulin was relatively immediate, whereas the effects on improvement in oral glucose tolerance were prolonged. We conclude that pancreatic polypeptide may function physiologically to enhance the hepatic glucose response to insulin and that alterations in glucose metabolism seen in chronic pancreatitis may be due, in part, to a deficiency in pancreatic polypeptide. Since treatment with continuous subcutaneous infusion of pancreatic polypeptide restored the hepatic response to insulin and oral glucose tolerance to more normal levels in our animal model, administration of pancreatic polypeptide may play a therapeutic role in the treatment of certain forms of pancreatogenic diabetes.

Citing Articles

Obesity is associated with impaired postprandial pancreatic polypeptide secretion.

Zhao Y, Zhou Y, Chi J, Che K, Wang Y, Wang W Front Endocrinol (Lausanne). 2023; 14:1192311.

PMID: 37334299 PMC: 10273268. DOI: 10.3389/fendo.2023.1192311.


Impaired glucose tolerance is associated with enhanced postprandial pancreatic polypeptide secretion.

Zhao Y, Zhou Y, Xiao M, Huang Y, Qi M, Kong Z J Diabetes. 2022; 14(5):334-344.

PMID: 35437937 PMC: 9366580. DOI: 10.1111/1753-0407.13268.


Mechanisms of Post-Pancreatitis Diabetes Mellitus and Cystic Fibrosis-Related Diabetes: A Review of Preclinical Studies.

Gal E, Dolensek J, Stozer A, Czako L, Ebert A, Venglovecz V Front Endocrinol (Lausanne). 2021; 12:715043.

PMID: 34566890 PMC: 8461102. DOI: 10.3389/fendo.2021.715043.


Evaluation of a Mixed Meal Test for Diagnosis and Characterization of PancrEaTogEniC DiabeTes Secondary to Pancreatic Cancer and Chronic Pancreatitis: Rationale and Methodology for the DETECT Study From the Consortium for the Study of Chronic....

Hart P, Andersen D, Mather K, Castonguay A, Bajaj M, Bellin M Pancreas. 2018; 47(10):1239-1243.

PMID: 30325863 PMC: 6195331. DOI: 10.1097/MPA.0000000000001168.


The Interface of Pancreatic Cancer With Diabetes, Obesity, and Inflammation: Research Gaps and Opportunities: Summary of a National Institute of Diabetes and Digestive and Kidney Diseases Workshop.

Abbruzzese J, Andersen D, Borrebaeck C, Chari S, Costello E, Cruz-Monserrate Z Pancreas. 2018; 47(5):516-525.

PMID: 29702529 PMC: 6361376. DOI: 10.1097/MPA.0000000000001037.